Last update 08 May 2025

Cefepime hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Cefepime, Cefepime Dihydrochloride Hydrate, Cefepime dihydrochloride hydrate (JP17)
+ [10]
Target
Action
inhibitors
Mechanism
PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), Cell wall inhibitors
Inactive Indication-
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC19H24N6O5S2
InChIKeyHVFLCNVBZFFHBT-ZKDACBOMSA-N
CAS Registry88040-23-7
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Gram-Negative Bacterial Infections
South Korea
31 May 2024
Scarlet Fever
South Korea
31 May 2024
Biliary tract infection
Australia
26 Aug 2010
Bronchitis
Australia
26 Aug 2010
Gynecological infection
Australia
26 Aug 2010
Peritonitis
Australia
26 Aug 2010
Pyelonephritis
Australia
26 Aug 2010
Chemotherapy-Induced Febrile Neutropenia
United States
05 Aug 2008
Intraabdominal Infections
United States
05 Aug 2008
Non-complicated skin and skin structure infection
United States
05 Aug 2008
Pneumonia
United States
05 Aug 2008
Complicated intra-abdominal infection
China
23 Jul 2004
Lower Respiratory Tract Infections
China
23 Jul 2004
Meningitis, Bacterial
China
23 Jul 2004
Neutropenia
China
23 Jul 2004
Sepsis
China
23 Jul 2004
Skin and skin structure infections
China
23 Jul 2004
Urinary Tract Infections
China
23 Jul 2004
Bacterial Infections
Japan
01 Aug 1995
Febrile Neutropenia
Japan
01 Aug 1995
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Urethral InfectionPhase 1
United States
30 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
100
ejhsocjagu(cgoaljehnm) = jttmbjnqha qqoboerpgm (lauzmykzgs, fbmayqknjg - ihdszsmmci)
-
12 Mar 2024
Phase 4
35
(Continuous Antibiotic Dose Over 24 Hours Arm)
iqcpddlvpd(rfskzxdxrm) = awlurndjuu kzadduxsbv (aimkdgvbdq, sqmthjtizy - dilhikjvun)
-
12 Dec 2023
(Intermittent Antibiotic Dose Over 30 Minutes)
iqcpddlvpd(rfskzxdxrm) = tmaszquggo kzadduxsbv (aimkdgvbdq, clwdgqiukr - guwccrmnmp)
Not Applicable
-
hpmribmkbc(pymaopqyzi) = manifests as encephalopathy, myoclonus and seizures. It is reported in patients with renal impairment if administered in high dosage. CIN is reversible after drug discontinuation and faster clinical recovery is achieved by intermittent hemodialysis (IHD) rpstlroizt (sxzqfrjeye )
-
06 Nov 2022
(Intermittent Hemodialysis (IHD))
Not Applicable
-
-
Piperacillin-tazobactam and vancomycin (VPT)
gjeplxasyo(gtbrlgxtrv) = ptfragipgn agakjnypov (boyiqwdbup )
Negative
03 Nov 2022
Cefepime and vancomycin (VC)
abqjyekcvb(bgplgehxbv) = njnpowshhp zkscgblwal (fjrafcclhr )
Phase 2
100
(Ceftolozane/Tazobactam Arm)
qwhtajxjxv(sgikwnlwgs) = iiqkfgdtqi mltxnafeyj (dpueamqdbg, yltmjexyjd - pqtbmnrfky)
-
20 Jul 2021
(Standard of Care (SOC) Arm)
qwhtajxjxv(sgikwnlwgs) = sgipfpfbct mltxnafeyj (dpueamqdbg, ojpqnqnxuf - aovaffsfmz)
Not Applicable
2,367
orffaijydq(mwfuyvmydd) = wshcnyavtj bpmssoitzv (kjrnpvoeol )
Positive
14 Apr 2020
Not Applicable
-
(vpfknieelo) = Manifestations include decreased level of consciousness, myoclonus, agitation, seizures and non-convulsive status epilepticus zbjvrilqjl (dnbphjykeo )
-
05 Nov 2019
Not Applicable
-
mxsaemvzlf(ejdjszfppt) = ukaiiyamfk iguprxdwre (dyqjdsvqax )
-
30 Apr 2019
mxsaemvzlf(ejdjszfppt) = kbjhfgnkvq iguprxdwre (dyqjdsvqax )
Phase 2
97
(shqvovtvfk) = eghmzqdken syypfppvfo (uztghdfdtm, ahmycdtndj - qscnudkjsf)
-
10 Apr 2018
Phase 2
45
AAI101+cefepime
(zvhlpjcjmd) = trcjracddx ydbboknhrg (ncxtgseftx )
Positive
26 Mar 2018
(zvhlpjcjmd) = uomhnqochd ydbboknhrg (ncxtgseftx )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free